ChristopherJamesDiBlasioMD

PubMed

• 15 citations
  Cryoablation for locally advanced clinical stage T3 prostate cancer: a report from the Cryo-On-Line Database (COLD) Registry.
  John F. Ward, Christopher J. DiBlasio, Christopher R. Williams, Robert Given, J. Stephen Jones
  BJU International. 2014-05-01
• 1 citations
  Nomogram to predict prostate cancer diagnosis on primary transrectal ultrasound-guided prostate biopsy in a contemporary series.
  Christopher J. DiBlasio, Ithaar Derweesh, Michael Maddox, Reza Mehrazin, Changhong Yu
  Current Urology. 2012-01-01
• 72 citations
  Feasibility and efficacy of neoadjuvant sunitinib before nephron‐sparing surgery
  Jonathan L. Silberstein, Frederick Millard, Reza Mehrazin, Ryan Kopp, Wassim M. Bazzi
  BJU International. 2010-11-01

Books/Book Chapters

• Managing Prostate Cancer 
  Chapter: Predictive outcomes: Artificial neural networks (ANN) and nomograms. 
  Rhee AC, DiBlasio CJ, Cho D, Kattan MWEditors: Klein, EA.Humana PressEdition 2nd,2003

Abstracts/Posters

• Inter- and intra-specialty analysis of “dead of disease” versus “dead with disease” in prostate cancer: is this a meaningful study end-point?
  Mehrazin R, Brahmbhatt J, Clendenin R, DiBlasio CJ, Wake RW, Derweesh IH, Aleman MA, American Urological Association, 104th Annual Meeting, Chicago, IL, 4/1/2009
• Peyronie’s disease has a negative impact on the durability and component malfunction rates in patients undergoing inflatable penile prosthesis implantation.
  DiBlasio CJ, Kurta J, Botta S, Mehrazin R, Brahmbhatt J, Wan JY, Derweesh IH, Aleman MA, Patterson AL, Wake RW, American Urological Association, 104th Annual Meeting, Chicago, IL, 4/1/2009
• Comparison of rates and risk factors for development of anemia following radical nephrectomy or partial nephrectomy.
  Bagrodia A, DiBlasio CJ, Malcolm JB, Mehrazin R, Silberstein J, Chenoweth M, Downs T, Kane CJ, Wake RW, Patterson AL, Wan JY, Derweesh IH, American Urological Association, 104th Annual Meeting, Chicago, IL, 4/1/2009
• Variations in incidence of and risk factors for development of osteoporosis and fractures after radical or partial nephrectomy.
  Bagrodia A, Mehrazin R, DiBlasio CJ, Malcolm JB, Silberstein J, Downs T, Chenoweth M, Wake RW, Kane CJ, Patterson AL, Wan JY, Derweesh IH, American Urological Association, 104th Annual Meeting, Chicago, IL, 4/1/2009
• Survey based analysis of radical and partial nephrectomy practice patterns during residency training.
  Brahmbhatt J, Mehrazin R, Derweesh IH, Aleman MA, Patterson AL, Wake RW, DiBlasio CJ, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series.
  DiBlasio CJ, Maddox M, Mehrazin R, Malcolm JB, Yu C, Aleman MA, Derweesh IH, Patterson AL, Wake RW, Kattan MW, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Peri-prostatic lidocaine anesthetic block during transrectal ultrasound-guided prostate biopsy is not associated with increased complication rates.
  DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
  DiBlasio CJ, Brahmbhatt J, Mehrazin R, Hammett J, Malcolm J, Womack J, Kincade M, Mancini J, Ogles M, Lamar K, Derweesh IH, Patterson AL, Wake RW, Judge B, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Survival outcomes in men treated with androgen deprivation therapy (ADT) as primary or salvage therapy: 20 year single-center experience.
  DiBlasio CJ, Hammett J, Malcolm JB, Kincade MC, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Peyronie’s disease has a negative impact on the durability and component malfunction rates in patients undergoing inflatable penile prosthesis implantation.
  DiBlasio CJ, Kurta J, Botta S, Mehrazin R, Brahmbhatt J, Wan JY, Derweesh IH, Aleman MA, Patterson AL, Wake RW, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Critical analysis of cause of death in prostate cancer patients receiving androgen deprivation therapy.
  Mehrazin R, Brahmbhatt J, Clendenin R, DiBlasio CJ, Wake RW, Derweesh IH, Aleman MA, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Is sutured repair necessary during laparoscopic partial nephrectomy.
  Mehrazin R, Derweesh IH, Christman M, Bagrodia A, Malcolm JB, DiBlasio CJ, Auge B, L'Esperance J, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Variation in incidence of and risk factors for development of osteoporosis after radical or partial nephrectomy.
  Bagrodia A, Mehrazin R, Malcolm JB, DiBlasio CJ, Patterson AL, Wan JY, Derweesh IH, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Comparison of rates and risk factors for development of chronic renal insufficiency, proteinuria, and metabolic acidosis following radial or partial nephrectomy.
  Bagrodia A, Mehrazin R, Malcolm JB, DiBlasio CJ, Wan JY, Patterson AL, Wake RW, Derweesh IH, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Difference in occurrence of and risk factors for development of nephrolithiasis after radical or partial nephrectomy.
  Bagrodia A, Mehrazin R, DiBlasio CJ, Malcolm JB, Wake RW, Patterson AL, Wan JY, Derweesh IH, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Nomogram to predict prostate cancer diagnosis on transrectal ultrasound-guided prostate biopsy in a contemporary series. (Poster)
  DiBlasio CJ, Maddox M, Mehrazin R, Malcolm JB, Yu C, Aleman MA, Derweesh IH, Patterson AL, Wake RW, Kattan MW, Southeastern Section American Urological Association 73rd Annual Meeting, Mobile, AL, 3/1/2009
• Peri-prostatic lidocaine anesthetic block during transrectal ultrasound-guided prostate biopsy is not associated with increased complication rates. (Podium)
  DiBlasio CJ, Mehrazin R, Maddox M, Brahmbhatt H, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake RW, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. (Podium)
  DiBlasio CJ, Brahmbhatt J, Mehrazin R, Hammett J, Malcolm J, Womack J, Kincade M, Mancini J, Ogles M, Lamar K, Derweesh IH, Patterson AL, Wake RW, Judge B, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Survival outcomes in men treated with androgen deprivation therapy (ADT) as primary or salvage therapy: 20 year single-center experience. (Poster)
  DiBlasio CJ, Hammett J, Malcolm JB, Kincade MC, Wan JY, Aleman MA, Derweesh IH, Patterson AL, Wake, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Peyronie’s disease has a negative impact on the durability and component malfunction rates in patients undergoing inflatable penile prosthesis implantation (Podium)
  DiBlasio CJ, Kurta J, Botta S, Mehrazin R, Brahmbhatt J, Wan JY, Derweesh IH, Aleman MA, Patterson AL, Wake RW, Southeastern Section American Urological Association, Mobile, AL, 3/1/2009
• Variation in incidence of and risk factors for the development of osteoporosis after radical or partial nephrectomy.
  Mehrazin R, DiBlasio CJ, Bagrodia A, Malcolm JB, Wan JY, Wake RW, Patterson AL, Derweesh IH, Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, 12/1/2008
• Assessment of risk factors for and comparison of rates of development of chronic renal insufficiency, proteinuria and metabolic acidosis following radical or nephron s...
  Mehrazin R, Bagrodia A, Malcolm JB, DiBlasio CJ, Wan JY, Patterson AL, Wake RW, Derweesh IH, Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, 12/1/2008
• Single center experience and intermediate-term outcomes of laparoscopic and percutaneous renal cryoablation for biopsy confirmed renal malignancy.
  Mehrazin R, Malcolm JB, DiBlasio CJ, Wake RW, Patterson AL, Gold R, Derweesh IH, Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, 12/1/2008
• Initial experience with laparoscopic partial nephrectomy for renal malignancy utilizing non-ischemic resection and sutureless renorrhaphy.
  Mehrazin R, DiBlasio CJ, Malcolm JB, Derweesh IH, Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, 12/1/2008
• Survey based analysis of radical nephrectomy practice patterns during residency training.
  Brahmbhatt J, Mehrazin R, Derweesh IH, Aleman MA, Patterson AL, Wake RW, DiBlasio CJ, Society of Urologic Oncology 9th Annual Meeting, Bethesda, MD, 12/1/2008
• Join now to see all

Lectures

• PSA screening recommendations in 2013: AUA guidelines. 
  9/1/2013
• Diagnosis and treatment of recurrent upper urinary tract transitional carcinoma following nephroureterectomy. 
  5/1/2013
• Case reviews in urology. 
  Huntington Hospital - 3/1/2013
• An update on contemporary treatment of castrate-resistant prostate cancer. 
  2/1/2013
• Potpourri of urological malignancy cases: transitional cell carcinoma of renal pelvis in a patient with history of partial nephrectomy for renal cell carcinoma, advanc... 
  1/1/2013
• HoLAP/HoLEP BPH treatments. 
  Huntington Hospital - 1/1/2013
• Novel agents for treatment of advanced castrate-resistant prostate cancer. 
  8/1/2012
• Laparoscopic approached to treatment of renal masses. 
  6/1/2012
• Laparoscopy in urology. 
  Huntington Hospital - 6/1/2012
• Upper urinary tract transitional cell carcinoma; an update. 
  3/1/2012
• Workup and treatment of small cell carcinoma of the kidney. 
  2/1/2012
• Treatment of testis cancer. 
  Huntington Hospital - 12/1/2011
• Urology case scenarios 
  12/1/2011
• Treatment of squamous cell carcinoma of the bladder. 
  11/1/2011
• Retirement planning for urologists. 
  Huntington Hospital - 5/1/2011
• Potpourri of urological malignancy cases: locally advanced bladder cancer, locally advanced renal cancer, urethral melanoma and testis cancer. 
  10/1/2010
• Urology and information technology. 
  Huntington Hospital - 10/1/2010
• A discussion of male urinary health and prostate disease in 2010. 
  New Island Hospital, Bethpage, NY - 9/1/2010
• Treatment of advanced renal cell carcinoma with vena cava involvement 
  7/1/2010
• BPH Medical Management 
  Huntington Hospital - 1/1/2010
• A discussion of male urinary health and prostate diseases in 2009. 
  Huntington, NY - 10/1/2009
• Retroperitoneal masses with renal involvement: diagnosis and treatment. 
  6/1/2009
• TURP/PVP - Combination - Old/New Conclusions 
  Huntington Hospital - 4/1/2009
• Cryoablation of contemporary renal and prostate cancer. 
  2/1/2009
• Nephron-sparing surgery for treatment of renal cancer. 
  1/1/2009
• Join now to see all